Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism
I. Gorodetska, V. Lukiyanchuk, M. Gawin, M. Sliusar, A. Linge, F. Lohaus, T. Hölscher, K. Erdmann, S. Fuessel, A. Borkowetz, M. Reardon, A. Choudhury, Y. Antonelli, A. Leal-Egana, A. S. Köseer, , A. Dubrovska
This study identifies MMP11 as a blood-based biomarker for prostate cancer progression, regulated by the ALDH1A1-TGF-β1 signaling pathway.
Journal of Experimental & Clinical Cancer Research · Mar 24, 2025Peer-reviewedCancer Biology